Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2012

Open Access 01-12-2012 | Research article

Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension

Authors: Hisham Aljadhey, Wanzhu Tu, Richard A Hansen, Susan J Blalock, D Craig Brater, Michael D Murray

Published in: BMC Cardiovascular Disorders | Issue 1/2012

Login to get access

Abstract

Background

Nonsteroidal anti-inflammatory drugs (NSAIDs) may disrupt control of blood pressure in hypertensive patients and increase their risk of morbidity, mortality, and the costs of care. The objective of this study was to examine the association between incident use of NSAIDs and blood pressure in patients with hypertension.

Methods

We conducted a retrospective cohort study of adult hypertensive patients to determine the effects of their first prescription for NSAID on systolic blood pressure and antihypertensive drug intensification. Data were collected from an electronic medical record serving an academic general medicine practice in Indianapolis, Indiana, USA. Using propensity scores to minimize bias, we matched a cohort of 1,340 users of NSAIDs with 1,340 users of acetaminophen. Propensity score models included covariates likely to affect blood pressure or the use of NSAIDs. The study outcomes were the mean systolic blood pressure measurement after starting NSAIDs and changes in antihypertensive therapy.

Results

Compared to patients using acetaminophen, NSAID users had a 2 mmHg increase in systolic blood pressure (95% CI, 0.7 to 3.3). Ibuprofen was associated with a 3 mmHg increase in systolic blood pressure compared to naproxen (95% CI, 0.5 to 4.6), and a 5 mmHg increase compared to celecoxib (95% CI, 0.4 to 10). The systolic blood pressure increase was 3 mmHg in a subgroup of patients concomitantly prescribed angiotensin converting enzyme inhibitors or calcium channel blockers and 6 mmHg among those prescribed a beta-adrenergic blocker. Blood pressure changes in patients prescribed diuretics or multiple antihypertensives were not statistically significant.

Conclusion

Compared to acetaminophen, incident use of NSAIDs, particularly ibuprofen, is associated with a small increase in systolic blood pressure in hypertensive patients. Effects in patients prescribed diuretics or multiple antihypertensives are negligible.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yach D, Hawkes C, Gould CL, Hofman KJ: The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA. 2004, 291 (21): 2616-2622. 10.1001/jama.291.21.2616.CrossRefPubMed Yach D, Hawkes C, Gould CL, Hofman KJ: The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA. 2004, 291 (21): 2616-2622. 10.1001/jama.291.21.2616.CrossRefPubMed
2.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003, 42 (6): 1206-1252. 10.1161/01.HYP.0000107251.49515.c2.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003, 42 (6): 1206-1252. 10.1161/01.HYP.0000107251.49515.c2.CrossRefPubMed
4.
go back to reference Johnson AG, Simons LA, Simons J, Friedlander Y, McCallum J: Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study. Br J Clin Pharmacol. 1993, 35 (5): 455-459. 10.1111/j.1365-2125.1993.tb04169.x.CrossRefPubMedPubMedCentral Johnson AG, Simons LA, Simons J, Friedlander Y, McCallum J: Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study. Br J Clin Pharmacol. 1993, 35 (5): 455-459. 10.1111/j.1365-2125.1993.tb04169.x.CrossRefPubMedPubMedCentral
5.
go back to reference Dedier J, Stampfer MJ, Hankinson SE, Willett WC, Speizer FE, Curhan GC: Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension. 2002, 40 (5): 604-608. 10.1161/01.HYP.0000035856.77718.DA.CrossRefPubMed Dedier J, Stampfer MJ, Hankinson SE, Willett WC, Speizer FE, Curhan GC: Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension. 2002, 40 (5): 604-608. 10.1161/01.HYP.0000035856.77718.DA.CrossRefPubMed
6.
go back to reference Kurth T, Hennekens CH, Sturmer T, Sesso HD, Glynn RJ, Buring JE, et al: Analgesic use and risk of subsequent hypertension in apparently healthy men. Arch Intern Med. 2005, 165 (16): 1903-1909. 10.1001/archinte.165.16.1903.CrossRefPubMed Kurth T, Hennekens CH, Sturmer T, Sesso HD, Glynn RJ, Buring JE, et al: Analgesic use and risk of subsequent hypertension in apparently healthy men. Arch Intern Med. 2005, 165 (16): 1903-1909. 10.1001/archinte.165.16.1903.CrossRefPubMed
7.
go back to reference Solomon DH, Schneeweiss S, Levin R, Avorn J: Relationship between COX-2 specific inhibitors and hypertension. Hypertension. 2004, 44 (2): 140-145. 10.1161/01.HYP.0000136134.31846.83.CrossRefPubMed Solomon DH, Schneeweiss S, Levin R, Avorn J: Relationship between COX-2 specific inhibitors and hypertension. Hypertension. 2004, 44 (2): 140-145. 10.1161/01.HYP.0000136134.31846.83.CrossRefPubMed
8.
go back to reference Wang J, Mullins CD, Mamdani M, Rublee DA, Shaya FT: New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study. Ann Pharmacother. 2007, 41 (6): 937-943. 10.1345/aph.1H659.CrossRefPubMed Wang J, Mullins CD, Mamdani M, Rublee DA, Shaya FT: New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study. Ann Pharmacother. 2007, 41 (6): 937-943. 10.1345/aph.1H659.CrossRefPubMed
9.
go back to reference Whelton A, Fort JG, Puma JA, Normandin D, Bello AE, Verburg KM: Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. Am J Ther. 2001, 8 (2): 85-95. 10.1097/00045391-200103000-00003.CrossRefPubMed Whelton A, Fort JG, Puma JA, Normandin D, Bello AE, Verburg KM: Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. Am J Ther. 2001, 8 (2): 85-95. 10.1097/00045391-200103000-00003.CrossRefPubMed
10.
go back to reference Davies JG, Rawlins DC, Busson M: Effect of ibuprofen on blood pressure control by propranolol and bendrofluazide. J Int Med Res. 1988, 16 (3): 173-181.PubMed Davies JG, Rawlins DC, Busson M: Effect of ibuprofen on blood pressure control by propranolol and bendrofluazide. J Int Med Res. 1988, 16 (3): 173-181.PubMed
11.
go back to reference Wright JT, McKenney JM, Lehany AM, Bryan DL, Cooper LW, Lambert CM: The effect of high-dose short-term ibuprofen on antihypertensive control with hydrochlorothiazide. Clin Pharmacol Ther. 1989, 46 (4): 440-444. 10.1038/clpt.1989.162.CrossRefPubMed Wright JT, McKenney JM, Lehany AM, Bryan DL, Cooper LW, Lambert CM: The effect of high-dose short-term ibuprofen on antihypertensive control with hydrochlorothiazide. Clin Pharmacol Ther. 1989, 46 (4): 440-444. 10.1038/clpt.1989.162.CrossRefPubMed
12.
go back to reference Klassen D, Goodfriend TL, Schuna AA, Young DY, Peterson CA: Assessment of blood pressure during treatment with naproxen or ibuprofen in hypertensive patients treated with hydrochlorothiazide. J Clin Pharmacol. 1993, 33 (10): 971-978.CrossRefPubMed Klassen D, Goodfriend TL, Schuna AA, Young DY, Peterson CA: Assessment of blood pressure during treatment with naproxen or ibuprofen in hypertensive patients treated with hydrochlorothiazide. J Clin Pharmacol. 1993, 33 (10): 971-978.CrossRefPubMed
13.
go back to reference Polonia J, Boaventura I, Gama G, Camoes I, Bernardo F, Andrade P, et al: Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients. J Hypertens. 1995, 13 (8): 925-931. 10.1097/00004872-199508000-00014.CrossRefPubMed Polonia J, Boaventura I, Gama G, Camoes I, Bernardo F, Andrade P, et al: Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients. J Hypertens. 1995, 13 (8): 925-931. 10.1097/00004872-199508000-00014.CrossRefPubMed
14.
go back to reference Houston MC, Weir M, Gray J, Ginsberg D, Szeto C, Kaihlenen PM, et al: The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil. Arch Intern Med. 1995, 155 (10): 1049-1054. 10.1001/archinte.1995.00430100075009.CrossRefPubMed Houston MC, Weir M, Gray J, Ginsberg D, Szeto C, Kaihlenen PM, et al: The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil. Arch Intern Med. 1995, 155 (10): 1049-1054. 10.1001/archinte.1995.00430100075009.CrossRefPubMed
15.
go back to reference Klassen DK, Jane LH, Young DY, Peterson CA: Assessment of blood pressure during naproxen therapy in hypertensive patients treated with nicardipine. Am J Hypertens. 1995, 8 (2): 146-153. 10.1016/0895-7061(94)00164-7.CrossRefPubMed Klassen DK, Jane LH, Young DY, Peterson CA: Assessment of blood pressure during naproxen therapy in hypertensive patients treated with nicardipine. Am J Hypertens. 1995, 8 (2): 146-153. 10.1016/0895-7061(94)00164-7.CrossRefPubMed
16.
go back to reference Gurwitz JH, Everitt DE, Monane M, Glynn RJ, Choodnovskiy I, Beaudet MP, et al: The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons. J Gerontol A Biol Sci Med Sci. 1996, 51 (2): M74-M79.CrossRefPubMed Gurwitz JH, Everitt DE, Monane M, Glynn RJ, Choodnovskiy I, Beaudet MP, et al: The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons. J Gerontol A Biol Sci Med Sci. 1996, 51 (2): M74-M79.CrossRefPubMed
17.
go back to reference Olsen ME, Thomsen T, Hassager C, Ibsen H, Dige-Petersen H: Hemodynamic and renal effects of indomethacin in losartan-treated hypertensive individuals. Am J Hypertens. 1999, 12 (2): 209-216. 10.1016/S0895-7061(98)00228-3.CrossRefPubMed Olsen ME, Thomsen T, Hassager C, Ibsen H, Dige-Petersen H: Hemodynamic and renal effects of indomethacin in losartan-treated hypertensive individuals. Am J Hypertens. 1999, 12 (2): 209-216. 10.1016/S0895-7061(98)00228-3.CrossRefPubMed
18.
go back to reference Morgan TO, Anderson A, Bertram D: Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J Hypertens. 2000, 13 (11): 1161-1167. 10.1016/S0895-7061(00)01204-8.CrossRefPubMed Morgan TO, Anderson A, Bertram D: Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J Hypertens. 2000, 13 (11): 1161-1167. 10.1016/S0895-7061(00)01204-8.CrossRefPubMed
19.
go back to reference Fogari R, Zoppi A, Carretta R, Veglio F, Salvetti A: Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study. J Hypertens. 2002, 20 (5): 1007-1014. 10.1097/00004872-200205000-00037.CrossRefPubMed Fogari R, Zoppi A, Carretta R, Veglio F, Salvetti A: Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study. J Hypertens. 2002, 20 (5): 1007-1014. 10.1097/00004872-200205000-00037.CrossRefPubMed
20.
go back to reference Whelton A, White WB, Bello AE, Puma JA, Fort JG: Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis. Am J Cardiol. 2002, 90 (9): 959-963. 10.1016/S0002-9149(02)02661-9.CrossRefPubMed Whelton A, White WB, Bello AE, Puma JA, Fort JG: Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis. Am J Cardiol. 2002, 90 (9): 959-963. 10.1016/S0002-9149(02)02661-9.CrossRefPubMed
21.
go back to reference White WB, Kent J, Taylor A, Verburg KM, Lefkowith JB, Whelton A: Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors. Hypertension. 2002, 39 (4): 929-934. 10.1161/01.HYP.0000014323.99765.16.CrossRefPubMed White WB, Kent J, Taylor A, Verburg KM, Lefkowith JB, Whelton A: Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors. Hypertension. 2002, 39 (4): 929-934. 10.1161/01.HYP.0000014323.99765.16.CrossRefPubMed
22.
go back to reference Palmer R, Weiss R, Zusman RM, Haig A, Flavin S, MacDonald B: Effects of nabumetone, celecoxib, and ibuprofen on blood pressure control in hypertensive patients on angiotensin converting enzyme inhibitors. Am J Hypertens. 2003, 16 (2): 135-139. 10.1016/S0895-7061(02)03203-X.CrossRefPubMed Palmer R, Weiss R, Zusman RM, Haig A, Flavin S, MacDonald B: Effects of nabumetone, celecoxib, and ibuprofen on blood pressure control in hypertensive patients on angiotensin converting enzyme inhibitors. Am J Hypertens. 2003, 16 (2): 135-139. 10.1016/S0895-7061(02)03203-X.CrossRefPubMed
23.
go back to reference Izhar M, Alausa T, Folker A, Hung E, Bakris GL: Effects of COX inhibition on blood pressure and kidney function in ACE inhibitor-treated blacks and hispanics. Hypertension. 2004, 43 (3): 573-577. 10.1161/01.HYP.0000115921.55353.e0.CrossRefPubMed Izhar M, Alausa T, Folker A, Hung E, Bakris GL: Effects of COX inhibition on blood pressure and kidney function in ACE inhibitor-treated blacks and hispanics. Hypertension. 2004, 43 (3): 573-577. 10.1161/01.HYP.0000115921.55353.e0.CrossRefPubMed
24.
go back to reference Sowers JR, White WB, Pitt B, Whelton A, Simon LS, Winer N, et al: The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Arch Intern Med. 2005, 165 (2): 161-168.CrossRefPubMed Sowers JR, White WB, Pitt B, Whelton A, Simon LS, Winer N, et al: The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Arch Intern Med. 2005, 165 (2): 161-168.CrossRefPubMed
25.
go back to reference Murray MD, Smith FE, Fox J, Teal EY, Kesterson JG, Stiffler TA, et al: Structure, functions, and activities of a research support informatics section. J Am Med Inform Assoc. 2003, 10 (4): 389-398. 10.1197/jamia.M1252.CrossRefPubMedPubMedCentral Murray MD, Smith FE, Fox J, Teal EY, Kesterson JG, Stiffler TA, et al: Structure, functions, and activities of a research support informatics section. J Am Med Inform Assoc. 2003, 10 (4): 389-398. 10.1197/jamia.M1252.CrossRefPubMedPubMedCentral
26.
go back to reference Ray WA: Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003, 158 (9): 915-920. 10.1093/aje/kwg231.CrossRefPubMed Ray WA: Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003, 158 (9): 915-920. 10.1093/aje/kwg231.CrossRefPubMed
27.
go back to reference American College of Rheumatology Subcommittee on Osteoarthritis Guidelines: Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum. 2000, 43 (9): 1905-1915.CrossRef American College of Rheumatology Subcommittee on Osteoarthritis Guidelines: Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum. 2000, 43 (9): 1905-1915.CrossRef
28.
go back to reference D’Agostino RB: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998, 17 (19): 2265-2281. 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B.CrossRefPubMed D’Agostino RB: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998, 17 (19): 2265-2281. 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B.CrossRefPubMed
29.
go back to reference Baser O: Too much ado about propensity score models? Comparing methods of propensity score matching. Value Health. 2006, 9 (6): 377-385. 10.1111/j.1524-4733.2006.00130.x.CrossRefPubMed Baser O: Too much ado about propensity score models? Comparing methods of propensity score matching. Value Health. 2006, 9 (6): 377-385. 10.1111/j.1524-4733.2006.00130.x.CrossRefPubMed
30.
go back to reference Zhang J, Yu KF: What’s the Relative Risk. JAMA. 1998, 280 (19): 1690-1691. 10.1001/jama.280.19.1690.CrossRefPubMed Zhang J, Yu KF: What’s the Relative Risk. JAMA. 1998, 280 (19): 1690-1691. 10.1001/jama.280.19.1690.CrossRefPubMed
31.
go back to reference Drug Facts and Comparisons: Facts & Comparisons 4.0. 2001, St. Louis, Mo: Wolters Kluwer Health Drug Facts and Comparisons: Facts & Comparisons 4.0. 2001, St. Louis, Mo: Wolters Kluwer Health
32.
go back to reference Tierney WM, Brunt M, Kesterson J, Zhou XH, L’Italien G, Lapuerta P: Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension. Ann Fam Med. 2004, 2 (3): 209-217. 10.1370/afm.76.CrossRefPubMedPubMedCentral Tierney WM, Brunt M, Kesterson J, Zhou XH, L’Italien G, Lapuerta P: Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension. Ann Fam Med. 2004, 2 (3): 209-217. 10.1370/afm.76.CrossRefPubMedPubMedCentral
33.
go back to reference Nietert PJ, Ornstein SM, Dickerson LM, Rothenberg RJ: Comparison of changes in blood pressure measurements and antihypertensive therapy in older, hypertensive, ambulatory care patients prescribed celecoxib or rofecoxib. Pharmacotherapy. 2003, 23 (11): 1416-1423. 10.1592/phco.23.14.1416.31935.CrossRefPubMed Nietert PJ, Ornstein SM, Dickerson LM, Rothenberg RJ: Comparison of changes in blood pressure measurements and antihypertensive therapy in older, hypertensive, ambulatory care patients prescribed celecoxib or rofecoxib. Pharmacotherapy. 2003, 23 (11): 1416-1423. 10.1592/phco.23.14.1416.31935.CrossRefPubMed
34.
go back to reference Lopez-Ovejero JA, Weber MA, Drayer JI, Sealey JE, Laragh JH: Effects of indomethacin alone and during diuretic or beta-adrenoreceptor-blockade therapy on blood pressure and the renin system in essential hypertension. Clin Sci Mol Med Suppl. 1978, 4: 203s-205s.PubMed Lopez-Ovejero JA, Weber MA, Drayer JI, Sealey JE, Laragh JH: Effects of indomethacin alone and during diuretic or beta-adrenoreceptor-blockade therapy on blood pressure and the renin system in essential hypertension. Clin Sci Mol Med Suppl. 1978, 4: 203s-205s.PubMed
35.
go back to reference Johnson AG, Nguyen TV, Day RO: Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med. 1994, 121 (4): 289-300.CrossRefPubMed Johnson AG, Nguyen TV, Day RO: Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med. 1994, 121 (4): 289-300.CrossRefPubMed
36.
go back to reference Davis A, Day RO, Begg EJ: Interactions between non-steroidal anti-inflammatory drugs and antihypertensives and diuretics. Aust N Z J Med. 1986, 16 (4): 537-546. 10.1111/j.1445-5994.1986.tb02031.x.CrossRefPubMed Davis A, Day RO, Begg EJ: Interactions between non-steroidal anti-inflammatory drugs and antihypertensives and diuretics. Aust N Z J Med. 1986, 16 (4): 537-546. 10.1111/j.1445-5994.1986.tb02031.x.CrossRefPubMed
37.
go back to reference Epstein M, Oster JR: Beta blockers and renal function: a reappraisal. J Clin Hypertens. 1985, 1 (1): 85-99.PubMed Epstein M, Oster JR: Beta blockers and renal function: a reappraisal. J Clin Hypertens. 1985, 1 (1): 85-99.PubMed
38.
go back to reference MacFarlane LL, Orak DJ, Simpson WM: NSAIDs, antihypertensive agents and loss of blood pressure control. Am Fam Physician. 1995, 51 (4): 849-856.PubMed MacFarlane LL, Orak DJ, Simpson WM: NSAIDs, antihypertensive agents and loss of blood pressure control. Am Fam Physician. 1995, 51 (4): 849-856.PubMed
39.
go back to reference American Diabetes Association: Standards of medical care in diabetes--2007. Diabetes Care. 2007, 30 (Suppl 1): S4-S41.CrossRef American Diabetes Association: Standards of medical care in diabetes--2007. Diabetes Care. 2007, 30 (Suppl 1): S4-S41.CrossRef
40.
go back to reference Grover SA, Coupal L, Zowall H: Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?. Hypertension. 2005, 45 (1): 92-97.CrossRefPubMed Grover SA, Coupal L, Zowall H: Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?. Hypertension. 2005, 45 (1): 92-97.CrossRefPubMed
41.
go back to reference Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002, 360 (9349): 1903-1913.CrossRefPubMed Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002, 360 (9349): 1903-1913.CrossRefPubMed
42.
go back to reference Sudano I, Flammer AJ, Périat D, Enseleit F, Hermann M, Wolfrum M, et al: Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation. 2010, 122 (18): 1789-1796. 10.1161/CIRCULATIONAHA.110.956490. Nov 2CrossRefPubMed Sudano I, Flammer AJ, Périat D, Enseleit F, Hermann M, Wolfrum M, et al: Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation. 2010, 122 (18): 1789-1796. 10.1161/CIRCULATIONAHA.110.956490. Nov 2CrossRefPubMed
43.
go back to reference Yood MU, Campbell UB, Rothman KJ, Jick SS, Lang J, Wells KE, et al: Using prescription claims data for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Saf. 2007, 16 (9): 961-968. 10.1002/pds.1454.CrossRefPubMed Yood MU, Campbell UB, Rothman KJ, Jick SS, Lang J, Wells KE, et al: Using prescription claims data for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Saf. 2007, 16 (9): 961-968. 10.1002/pds.1454.CrossRefPubMed
Metadata
Title
Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension
Authors
Hisham Aljadhey
Wanzhu Tu
Richard A Hansen
Susan J Blalock
D Craig Brater
Michael D Murray
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2012
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-12-93

Other articles of this Issue 1/2012

BMC Cardiovascular Disorders 1/2012 Go to the issue